@engstr_thomas

Professor, Cardiologist in Interventional Cardiology, PhD, DMSc at Rigshospitalet, Copenhagen University Hospital, Denmark.

 Copenhagen, Denmark
Joined June 2017
  • Tweets11
  • Following73
  • Followers136
Thomas Engstrøm retweeted
RigsHeart 🫀🚨@RigsHeart4 Oct 2022
🫀👩🏻‍⚕️Dr. @JasmineMMadsen this morning presenting the PULSE-MI trial that will be starting November 14th, 2022📣📣 The trial will investigate whether pulse-dose glucocorticoid in the pre-hospital setting reduces final infarct size in #STEMI patients treated with primary PCI! 🚑 🚨
1
3
2
19
Important topic in the digital era. nejm.org/doi/full/10.1056/NE…
1
1
1
11
I’ll be watching! Will you? 🤔 #EuroPCR #RigsHeart @PCRonline
RigsHeart 🫀🚨@RigsHeart18 May 2022
📣📣 Dr. Jacob Lønborg from @Rigshospitalet will be presenting #CTO techniques to treat complications during #pPCI for #STEMI. 🫀🏥 Tab in online or join the session on-site at 11:01 am (CET) at #EuroPCR 📅🔥 #RigsHeart @Rigshospitalet @PCRonline
15
Thomas Engstrøm retweeted
RigsHeart 🫀🚨@RigsHeart18 May 2022
❌📣 Lars Søndergaard will talk about where we stand on interventions for aortic valve disease in 2022 tomorrow at #EuroPCR at 18.10 (CET)! 📣 Join online from home or watch on-site! 👏🏼 See you there! 🔥 #RigsHeart @Rigshospitalet @HeartCopenhagen @PCRonline
5
12
Thomas Engstrøm retweeted
Davide Capodanno
@DFCapodanno18 May 2022
There is a paucity of standardization and comparability across studies involving coronary bifurcation lesions. The BIF-ARC document (first joint publication of @EuroInterventio and @JACCJournals) provides definitions and criteria for use in such studies. eurointervention.pcronline.c…
2
33
4
67
Thomas Engstrøm retweeted
Gregg W. Stone MD@GreggWStone3 May 2022
EROSION III: OCT led to less infarct lsn stenting. No MI/ST in 1y FU, but article doesn’t stress that TLR was 0/116 (0%) in stented pts vs 9/110 (8.2%) with Med Rx for recurrent symptoms. IMO this supports routine stenting in these non-obstr lsns absent an adequately powered RCT.
5
10
2
49
Very excited to be part of PACMAN-AMI! 🫀
RigsHeart 🫀🚨@RigsHeart16 May 2022
In this study published in @JAMA_current, addition of PCSK9i to high-intensity statin therapy following AMI, led to greater coronary plaque regression. Congrats to @engstr_thomas and the team behind the PACMAN-AMI trial 👏🫀🚨 #JAMAJournals #RigsHeart jamanetwork.com/journals/jam…
1
4
Thomas Engstrøm retweeted
RigsHeart 🫀🚨@RigsHeart15 May 2022
Up to 70% of patients with angina undergoing CAG do not have obstructive coronary artery disease (INOCA). In this review by @JasmineMMadsen, the authors dig deep into why a complete invasive diagnosis of patients with INOCA matters 🫀🚨 #RigsHeart doi.org/10.1080/14737159.202…
4
1
13
Load more